Welcome to our dedicated page for COMPOSECURE SEC filings (Ticker: CMPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CompoSecure’s filings aren’t your typical single-line card manufacturer reports. Each 10-K blends production costs for premium metal payment cards with SaaS-style revenue from the Arculus security platform, while every 8-K details rapid-fire fintech developments. Finding where supply-chain risks end and crypto-wallet disclosures begin can feel impossible.
That’s why Stock Titan pairs real-time EDGAR feeds with AI-powered summaries. Open a CompoSecure annual report 10-K simplified and our engine highlights segment margins, patent litigation, and sustainability spending in plain English. Need the CompoSecure quarterly earnings report 10-Q filing? We surface card unit volumes and Arculus subscriber growth instantly. Track CompoSecure insider trading Form 4 transactions or set alerts for CompoSecure Form 4 insider transactions real-time to see when executives exercise options. Our platform even breaks down the CompoSecure proxy statement executive compensation so you can gauge incentive alignment, and flags any CompoSecure 8-K material events explained—from new issuer partnerships to supply disruptions.
Whether you’re modeling future cash flows, monitoring CompoSecure earnings report filing analysis, or simply understanding CompoSecure SEC documents with AI, you’ll save hours. Investors use these insights to compare metal card gross margins quarter-over-quarter, spot insider buying ahead of product launches, and assess CompoSecure executive stock transactions Form 4 against market moves. All filings, all forms, always up to date—clarity delivered when you need it.
CompoSecure, Inc. filed a Form 144 reporting a proposed sale of 1,000 shares of common stock through Edward Jones (201 Progress Parkway, Maryland Heights, MO). The filing lists an aggregate market value of $17,960, states 102,317,852 shares outstanding, and gives an approximate date of sale of 08/12/2025 with the exchange listed as "Nadaq."
The securities were acquired via RSU vesting on 01/01/2023 (62,500 shares) and 01/01/2024 (37,500 shares). The filer certifies they do not know of undisclosed material adverse information and reports nothing to report for securities sold in the past three months.
Q2-25 10-Q highlights (post spin-off & equity-method shift)
On 28-Feb-25 CompoSecure (CMPO) spun off Resolute Holdings and ceded control of operating subsidiary CompoSecure Holdings, L.L.C. (“Holdings”). Holdings is now carried as an equity-method investment. As a result, CMPO no longer records revenue or cost of sales; instead it reports its share of Holdings’ profit.
Income statement: For the quarter ended 30-Jun-25 CMPO booked $38.9 m of equity-method earnings, offset by non-cash fair-value losses on warrants (-$53.4 m) and earn-out liabilities (-$10.7 m). SG&A was $2.7 m. Net loss attributable to CMPO was -$26.1 m (-$0.26 per share) versus $33.6 m profit a year earlier.
Balance sheet: Deconsolidation shrank assets to $317 m from $474 m at 31-Dec-24. Cash fell sharply to $4.8 m. A $44.7 m equity-method asset was recognized. Liabilities declined to $424 m but still exceed assets, leaving a stockholders’ deficit of $106 m. Warrant liability expanded to $137.4 m.
Cash flow & liquidity: Operating cash inflow was $3.0 m YTD; $60.7 m was used in investing, mainly removal of Holdings’ cash. Financing outflow was $15.0 m. Net cash burn of $72.7 m heightens liquidity risk; CMPO depends on distributions from Holdings.
- 102.4 m Class A shares outstanding; dual-class structure eliminated.
- Deferred tax asset stands at $266.7 m.
Key takeaway: Equity-method profits remain solid, but parent-level cash is thin and non-cash mark-to-market items drive volatile GAAP results.
Form 4 highlights — CompoSecure, Inc. (CMPO)
- Reporting person: Director Kevin M. Moriarty
- Transaction date: 07/29/2025
- Security: Stock option granting the right to purchase 6,998 Class A shares
- Exercise price: $13.80 per share
- Vesting: 25 % on 07/29/2026 and 25 % on each of the following three anniversaries (fully vested 07/29/2029)
- Expiration: 07/29/2035
- Consideration: Options issued in lieu of the $50,000 annual cash retainer under the Non-Employee Director Compensation Policy
- Ownership after grant: 6,998 derivative securities held directly
No open-market purchase or sale of shares occurred; the filing records a compensatory grant that modestly increases potential future dilution but strengthens management–shareholder alignment.
FAQ
What is the current stock price of COMPOSECURE (CMPO)?
What is the market cap of COMPOSECURE (CMPO)?
